The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection

Journal of Immunological Methods

Volumn 320, Issue 1-2, 2007, Pages 49-57

  Steyaert, Sophia ^a   Verhoye, Lieven ^a   Beirnaert, Els ^b   Donners, Helen ^b   Fransen, Katrien ^b   Heyndrickx, Leo ^b   Vanham, Guido ^b,c   Leroux Roels, Geert ^a   Vanlandschoot, Peter ^a  

^a GHENT UNIVERSITY   (Belgium)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

HIV; Human; Hybridoma; Monoclonal antibody; NOD SCID

Indexed keywords

MONOCLONAL ANTIBODY; P24 MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY ISOLATION; ANTIGEN ANTIBODY REACTION; ARTICLE; B LYMPHOCYTE; BLOOD; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; MEMORY CELL; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPLEEN; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; DRUG ADMINISTRATION ROUTES; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MODELS, ANIMAL; SPLEEN; VIRAL LOAD;

ANIMALIA; MUS;

EID: 33847373833     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.12.003     Document Type: Article

References (43)

1. Amadori A., DeRossi A., Faulkner-Valle G.P., and Chieco-Bianchi L. Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects. Clin. Immunol. Immunopathol. 46 (1988) 342
2. Amadori A., Zamarch R., Ciminale V., Del Mistro A., Siervo S., Alberti A., Colombatti M., and Chieco-Bianchi L. HIV-1 specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J. Immunol. 143 (1989) 2146
3. Andreoni M., Parisi S.G., Sarmati L., Nicastri E., Ercoli L., Mancino G., Sotgiu G., Mannazzu M., Trevenzoli M., Tridente G., Concia E., and Aceti A. Cellular proviral HIV-DNA decline and viral isolation in naive subjects with < 5000 copies/ml of HIV-RNA and > 500 × 10(6)/l CD4 cells treated with highly active antiretroviral therapy. AIDS 14 (2000) 23
4. Binley J.M., Klasse P.J., Cao Y., Jones I., Markowitz M., Ho D.D., and Moore J.P. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J. Virol. 71 (1997) 2799
5. Borkow G. Mouse models for HIV-1 infection. IUBMB Life 57 (2005) 819
6. Buchacher A., Predl R., Strutzenberger K., Steinfellner W., Trkola A., Purtscher M., Gruber G., Tauer C., Steindl F., Jungbauer A., and Katinger H. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res. Hum. Retrovir. 10 (1994) 359
7. Cao T., Lazdina U., Desombere I., Vanlandschoot P., Milich D.R., Sällberg M., and Leroux-Roels G. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: Studies with a human PBL-NOD/SCID mouse model. J. Virol. 75 (2001) 6359
8. Cheingsong-Popov R., Panagiotidi C., Bowcock S., Aronstam A., Wadsworth J., and Weber J. Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection. BMJ 302 (1991) 23
9. Chong Y., Ikematsu H., Kikuchi K., Yamamoto M., Murata M., Nishimura M., Nabeshima S., Kashiwagi S., and Hayashi J. Selective CD27+ (memory) B cell reduction and characteristic Bcell alteration in drug-naive and HAART-treated HIV type 1-infected patients. AIDS Res. Hum. Retrovir. 20 (2004) 219
10. Conge A.-M., Tarte K., Reynes J., Segondy M., Gerfaux J., Zembala M., and Vendrell J.-P. Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease. AIDS 12 (1998) 1437
11. De Milito A., Morch C., Sonnerborg A., and Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 15 (2001) 957
12. Depraetere S., Verhoye L., Leclercq G., and Leroux-Roels G. Human B cell growth and differentiation in the spleen of immunodeficient mice. J. Immunol. 166 (2001) 2929
13. Fondere J.-M., Huguet M.-F., Yssel H., Baillat V., Reynes J., van de Perr P., and Vendrell J.-P. Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy. AIDS 17 (2003) 2323
14. Fondere J.-M., Huguet M.-F., Macura-Biegun A., Baillat V., Ohayon V., Reynes J., and Vendrell J.-P. Detection and enumeration of circulating HIV-1-specific Memory B cells in HIV-1-infected patients. J. Acquir. Immune Defic. Syndr. 35 (2004) 114
15. Gorny M.K., Gianakakos V., Sharpe S., and Zolla-Pazner S. Generation of human monoclonal antibodies to human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 1624
16. Hogervorst E., Jurriaans S., de Wolf F., van Wijk A., Wiersma A., Valk M., Roos M., van Genem B., Coutinho R., Miedema F., and Goudsmit J. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J. Infect. Dis. 171 (1995) 811
17. Indraccolo S., Mion M., Zamarchi R., Veronesi A., Veronese M.L., Panozzo M., Betterle C., Barelli A., Borri A., Amadori A., and Chieco-Bianchi L. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets. J. Clin. Immunol. 13 (1993) 381
18. Lane H.C., Masur H., Edgar L.C., Whalen G., Rook A.H., and Fauci A.S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309 (1983) 453
19. Martinez-Maza O., Crabb E., Mitsuyasu R.T., Fahey J.L., and Giorgi J.V. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J. Immunol. 138 (1987) 3720
20. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., and Weissman I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241 (1988) 1632
21. Moir S., Malaspina A., Ogwaro K.M., Donoghue E.T., Hallahan C.W., Ehler L.A., Liu S.Y., Adelsberger J., Lapointe R., Hwu P., Baseler M., Orenstein J.M., Chun T.W., Mican J.A.M., and Fauci A.S. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10362
22. Moir S., Malaspina A., Pickeral O.K., Donoghue E.T., Vasquez J., Miller N.J., Krishnan S.R., Planta M.A., Turney K.F., Justement J.S., Kottilil S., Dyubul M., Mican J.M., Kovacs C., Chun T.W., Birse C.E., and Fauci A.S. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J. Exp. Med. 200 (2004) 587
23. Morris L., Binley J.M., Clas B.A., Bonhoeffer S., Astill T.P., Kost R., Hurley A., Cao Y., Markowitz M., Ho D.D., and Moore J.P. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J. Exp. Med. 188 (1998) 233
24. Mosier D.E., Gulizia R.J., Baird S.M., and Wilson D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335 (1988) 256
25. Mosier D.E., Gulizia R.J., Baird S.M., Wilson D.B., Spector D.H., and Spector S.A. Human immunodeficiency virus infection of human-PBL-Scid mice. Science 251 (1991) 791
26. Murphy W.J., Taub D.D., and Longo D.L. The huPBL-SCID mouse as a means to examine human immune function in vivo. Semin. Immunol. 8 (1996) 233
27. Ngo-Giang-Huong N., Deveau C., Da Silva I., Pellegrin I., Venet A., Harzic M., Venet A., Harzic M., Sinet M., Delfraissy J.F., Meyer L., Goujard C., and Rouzioux C. Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy. AIDS 15 (2001) 665
28. Samuelsson A., Sonnerborg A., Heuts N., Coster J., and Chiodi F. Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retrovir. 13 (1997) 1031
29. Schmidt G., Amiraian K., Frey H., Wethers J., Stevens R.W., and Berns D.S. Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24. J. Clin. Microbiol. 27 (1989) 843
30. Schoonjans F., Zalata A., Depuydt C.E., and Comhaire F.H. Medcalc: a new computer program for medical statistics. Comput. Methods Program. Biomed. 48 (1995) 257
31. Shirai A., Cosentino M., Leitman-Klinman S.F., and Klinman D.M. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cells activation. J. Clin. Invest. 89 (1992) 561
32. Shultz L.D., Schweitzer P.A., Christianson S.W., Gott B., Schweitzer I.B., Tennent B., McKenna S., Mobraaten L., Rajan T.V., Greiner D.L., and Leiter E.H. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154 (1995) 180
33. Steyaert, S., Heyndrickx, L., Verhoye, L, Vermoesen, T., Donners, H., Fransen, K., Van Wanzeele, F., Vandergucht, B., Vanham, G., Leroux-Roels, G., Vanlandschoot, P., in press. Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients. Antiviral Res.
34. Strathdee S.A., Frank J.W., McLaughlin J., Leblanc M., Major C., O'Shaughnessy M.V., and Read S.E. Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS. J. Infect. Dis. 172 (1995) 1375
35. Tanaka T., Tsudo M., Karasuyama H., Kitamura F., Kono T., Hatakeyama M., Taniguchi T., and Miyasaka M. A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J. Immunol. 147 (1991) 2222
36. Tanaka T., Kitamura F., Nagasaka Y., Kuida K., Suwa H., and Miyasaka M. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J. Exp. Med. 178 (1993) 1103
37. Titanji K., De Milito A., Cagigi A., Thorstensson R., Grützmeier S., Atlas A., Hejdeman B., Kroon F.P., Lopalco L., Nilsson A., and Chiodi F. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108 (2006) 1580
38. Tournoy K.G., Depraetere S., Pauwels R.A., and Leroux-Roels G.G. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice. Clin. Exp. Immunol. 119 (2000) 231
39. Traggiai E., Becker S., Subbarao K., Kolesnikova L., Uematsu Y., Gismondo M.R., Murphy B.R., Rappuoli R., and Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10 (2004) 871
40. Trkola A., Kuster H., Leemann C., Oxenius A., Fagard C., Furrer H., Battegay M., Vernazza P., Bernasconi E., Weber R., Hirschel B., Bonhoeffer S., and Gunthard H.F. Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point. Blood 104 (2004) 1784
41. Vanlandschoot P., Van Houtte F., Roobrouck A., Farhoudi A., and Leroux-Roels G. Hepatitis B surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor. J. Gen. Virol. 83 (2002) 1281
42. Yarchoan R., Redfield R.R., and Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. J. Clin. Invest. 78 (1986) 439
43. Zwart G., van der Hoek L., Valk M., Cornelissen M.T., Baan E., Dekker J., Koot M., Kuiken C.L., and Goudsmit J. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression. Virology 201 (1994) 285